Clinical Trials Browser

Phase 1/2 × OTHER × lutetium Lu 177 dotatate × Clear all

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms

NCT04261855 2025-02-14

GoTHAM

Phase 1/2 Recruiting

19 enrolled

DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT04614766 2024-04-29

SPORE-3

Phase 1/2 Withdrawn

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

NCT03923257 2021-06-08

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents

Phase 1/2 Withdrawn

CNSEndocrineNET

Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

Clinical Trials

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

GoTHAM

SPORE-3

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents